UnitedHealth (UNH) is trading just 2.2% below its 52-week high. The stock is up 41.3% over the past year. Its Performance Score sits at just 3.0 out of 10.
That's one of the weakest readings anywhere in managed care. Q2 earnings land Thursday, July 16, before the market opens. That report is what settles the argument between the price chart and the scorecard.
UnitedHealth's rally, by the numbers
The move has been steady, not sudden. UNH gained 3.9% over the past month, 39.5% over three months, and 24.7% over six months. Analysts expect Q2 adjusted EPS of roughly $4.84, up 18.6% from a year ago.
Zoom out further and the picture flips. UNH's 3-year price return is still negative 6.0%. Its 5-year return is barely positive at 2.1%.
The stock spent most of the last two years climbing out of a hole. That longer stretch still weighs on how the score reads it today.
UnitedHealth's earnings track record
Last year's Q2 report was the low point. UNH posted EPS of $4.08 against a $4.84 estimate, a miss of 15.7%. That was the quarter medical costs blew past every plan.
It set a low bar for this year.
Every quarter since has beaten estimates. Q3 2025 EPS came in at $2.92 against a $2.75 estimate. Q4 2025 beat by a slimmer margin, $2.11 versus $2.09.
Q1 2026 was the strongest beat of the stretch. EPS came in at $7.23 against a $6.56 estimate, a surprise of just over 10%. Three straight quarters, three straight beats.
Now the estimate is back near where it broke last year. Analysts expect Q2 2026 EPS of roughly $4.84, up 18.6% from a year ago. Revenue is projected at about $110.9 billion, essentially flat versus last year.
A beat here would make it four in a row. A miss would reopen the exact wound that hit the stock last July.
What UnitedHealth's Health Score reveals
UNH's Health Score is 6.0 out of 10. That ranks second among the 10 largest names in managed care, behind only Cigna (CI). It puts UnitedHealth (UNH) ahead of CVS Health (CVS), Humana (HUM), and Elevance Health (ELV).
The cash flow behind the score
Free cash flow per share sits at $21.61, and operating cash flow per share is $25.44. That's the main driver of the score. It gives UNH room to keep raising its dividend even while medical costs stay elevated.
Where the score loses points
The current ratio is 0.83, meaning current liabilities outweigh current assets. Net profit margin has been squeezed to 2.68% by rising medical costs.
A single basis point move in UnitedHealth's medical cost ratio swings tens of millions in pretax earnings. That's why margin trends matter more here than the stock price.
Why UnitedHealth's Performance Score lags the rally
A Performance Score of 3.0 puts UNH seventh of 10 in its industry. It trails Oscar Health (OSCR), CVS, and Humana on this metric.
That looks strange next to a stock sitting near its highs. It isn't. The score weighs multiple time horizons, and UNH's longer stretches are still weak.
A stock can lead its sector this quarter and still carry a below-average score. That happens when the multi-year chart hasn't caught up yet. It's exactly UNH's situation right now.
Stoxcraft scores are quantitative indicators based on Financial Modeling Prep data. They are not a recommendation to buy or sell any security. Investing involves risk, including loss of principal.
What the trend and entry signal say right now
The near-term picture is more encouraging. RSI at 59 signals steady buying pressure without the overbought readings that typically attract profit-taking. The stock sits within 2.2% of its 52-week high, and the entry signal currently reads Buy.
The average analyst price target is $431.88, only about 1.7% above the current price. Wall Street likes the setup. There just isn't much room left before UNH catches up to that target.
UnitedHealth vs. the rest of managed care
On risk, UNH ranks as the second-least volatile name in the group. Its Risk Score of 3.9 (higher means more risk) trails only Cigna's.
Beta sits at just 0.63. The max drawdown over the past 12 months is a modest 5.6%. Elevance Health (ELV) and Humana both carry higher risk readings.
The overall rating tells the fuller story. UNH's 3-star rating ties for the best in managed care, alongside Cigna, CVS, and Oscar Health.
Strong fundamentals and low risk are carrying the rating. The performance side is what still lags.
The one report that decides UnitedHealth's next move
UNH looks less like a stock riding pure hype. It looks more like a name still proving its recovery is real. Solid fundamentals, low risk, and a favorable entry signal support the rally.
A soft multi-year track record holds it back. So does the thin upside left to the price target.
Thursday's earnings report is the next data point that moves this either way. A clean beat on margins would start closing the gap between the price chart and the score. Whichever way it breaks, the score will catch up fast.
Stoxcraft scores are quantitative indicators based on Financial Modeling Prep data. They are not a recommendation to buy or sell any security.
Investing involves risk, including loss of principal. Past performance does not guarantee future results.
